I do not think a peer reviewed publication has been spoiled. On the contrary it will be big when it drops if it confirms all the positive results we've heard so far.
I believe this stock is heavily de-risked already, once we get a positive the peer review, it's smooth sailing. I'm not going to make a specific price prediction but I think it will be much more than your estimate, respectfully. FDA approval is one of the ultimate goals but that's not the only thing that will lift the PPS into uplist territory.